Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $15.1 million.

  • Lemaitre Vascular's Cost of Revenue fell 1445.5% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.9 million, marking a year-over-year increase of 366.77%. This contributed to the annual value of $69.0 million for FY2024, which is 380.37% up from last year.
  • Per Lemaitre Vascular's latest filing, its Cost of Revenue stood at $15.1 million for Q3 2025, which was down 1445.5% from $19.3 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Cost of Revenue ranged from a high of $19.3 million in Q2 2025 and a low of $12.1 million during Q1 2021
  • In the last 5 years, Lemaitre Vascular's Cost of Revenue had a median value of $15.6 million in 2023 and averaged $15.7 million.
  • In the last 5 years, Lemaitre Vascular's Cost of Revenue surged by 7781.9% in 2021 and then plummeted by 1445.5% in 2025.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Cost of Revenue stood at $13.5 million in 2021, then increased by 9.99% to $14.9 million in 2022, then rose by 4.82% to $15.6 million in 2023, then rose by 9.66% to $17.1 million in 2024, then decreased by 11.89% to $15.1 million in 2025.
  • Its Cost of Revenue stands at $15.1 million for Q3 2025, versus $19.3 million for Q2 2025 and $18.5 million for Q1 2025.